Resection of Liver Metastases: A Treatment Provides a Long-Term Survival Benefit for Patients with Advanced Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis

Figure 2

Forest plot for the occurrence time of hepatic metastases (synchronous/metachronous) of liver resection group and nonliver resection group in patients with liver metastases from pancreatic neuroendocrine tumor. There is no significant difference between two groups.